Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | Syncona Limited (Ordinary Share) | -17.07% |
NAV | Syncona Limited (Ordinary Share) | -2.35% |
Morningstar's Benchmark | FTSE 250 TR GBP | -- |
- Transaction in Own Shares
- Century Therapeutics to acquire Clade Therapeutics
- Achilles reports full year 2023 Financial Results
- Achilles provides clinical data update
- Total Voting Rights
- Autolus reports full year 2023 Financial Results
- Director Declaration
- Acquisition of Freeline Becomes Effective
- Freeline Shareholders Approve Acquisition
- Autolus offering (Amendment)
More ▼
Key statistics
On Thursday, Syncona Limited (SYNC:LSE) closed at 123.40, 17.52% above the 52 week low of 105.00 set on Sep 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 654.08m |
---|---|
Market cap | 810.53m GBP |
Total assets | 1.23bn GBP |
Total expense ratio | 0.92% |
High | 124.20 |
Low | 123.00 |
Previous close | 123.40 |
Average volume | 446.45k |
---|---|
YTD Change | 0.00% |
Beta | 0.3384 |
Diluted NAV (est) | 188.20 |
Diluted NAV (last pub) | 188.20 |
Premium/Discount | -34.43% |
Net Gearing | 0.00% |
Data delayed at least 20 minutes, as of Apr 18 2024 17:35 BST.
More ▼